Skip to content

The modified Dixon sequential method for determining the ED50 of oliceridine fumarate combined with ciprofol for pediatric lumbar puncture

The modified Dixon sequential method for determining the ED50 of oxaliplatin fumarate combined with cyclosporine for pediatric lumbar puncture

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600123626
Enrollment
Unknown
Registered
2026-04-28
Start date
2026-05-01
Completion date
Unknown
Last updated
2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematologic malignancies

Interventions

Group A:oliceridine fumarate was slowly injected intravenously according to the modified sequential method, and ciprofol 0.5 mg/kg was slowly injected intravenously over

Sponsors

Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 16 Years

Inclusion criteria

Inclusion criteria: 1.Children aged between 8 and 16 years old who require lumbar puncture due to clear clinical diagnosis; 2. The American Society of Anesthesiologists (ASA) classification is I-III, indicating that the child's physical condition can tolerate lumbar puncture procedures and related drug interventions; 3. The guardian of the patient fully understands the purpose, methods, potential risks, and expected benefits of this study, and voluntarily signs an informed consent form to ensure that the study is conducted in accordance with ethical standards.

Exclusion criteria

Exclusion criteria: 1. Children with a clear history of allergies tooliceridine fumarate or similar drugs should avoid severe allergic reactions; 2. Children with severe liver and kidney dysfunction, as abnormal liver and kidney function may affect the metabolism and excretion of drugs, thereby increasing the risk of adverse drug reactions; 3. Children with neurological disorders that may interfere with the accuracy of motor judgment, such as severe cerebral palsy, status epilepticus, etc., should ensure the reliability of the primary outcome measures; 4. For children who have recently (within one week) used other potent analgesics or drugs that affect neurological function, prevent drug interactions from interfering with research results.

Design outcomes

Primary

MeasureTime frame
Movement response;

Secondary

MeasureTime frame
Numerical Rating Scale point;Modified Observer's Assessment of Alertness and Sedation;

Countries

China

Contacts

Public ContactYun'an Song

Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University

songyunan168@sina.com+86 139 1846 3376

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 7, 2026